Trexquant Investment’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $360K | Buy |
+10,894
| New | +$360K | ﹤0.01% | 1343 |
|
|
2024
Q3 | – | Sell |
-28,508
| Closed | -$1.54M | – | 1584 |
|
|
2024
Q2 | $1.54M | Sell |
28,508
-77,631
| -73% | -$4.21M | 0.02% | 840 |
|
|
2024
Q1 | $7.44M | Sell |
106,139
-3,671
| -3% | -$257K | 0.15% | 194 |
|
|
2023
Q4 | $9.17M | Buy |
109,810
+88,342
| +412% | +$7.38M | 0.21% | 114 |
|
|
2023
Q3 | $632K | Buy |
+21,468
| New | +$632K | 0.02% | 922 |
|
|
2021
Q3 | – | Sell |
-19,266
| Closed | -$381K | – | 1207 |
|
|
2021
Q2 | $381K | Buy |
+19,266
| New | +$381K | 0.03% | 608 |
|
|
2020
Q4 | – | Sell |
-31,092
| Closed | -$673K | – | 1101 |
|
|
2020
Q3 | $673K | Sell |
31,092
-10,781
| -26% | -$233K | 0.04% | 557 |
|
|
2020
Q2 | $987K | Sell |
41,873
-24,252
| -37% | -$572K | 0.07% | 404 |
|
|
2020
Q1 | $780K | Buy |
66,125
+35,493
| +116% | +$419K | 0.06% | 494 |
|
|
2019
Q4 | $325K | Buy |
+30,632
| New | +$325K | 0.02% | 712 |
|
|
2019
Q1 | – | Sell |
-44,016
| Closed | -$278K | – | 1047 |
|
|
2018
Q4 | $278K | Buy |
+44,016
| New | +$278K | 0.02% | 812 |
|
|
2018
Q1 | – | Sell |
-14,470
| Closed | -$118K | – | 1129 |
|
|
2017
Q4 | $118K | Buy |
14,470
+3,914
| +37% | +$31.9K | 0.01% | 998 |
|
|
2017
Q3 | $153K | Sell |
10,556
-4,375
| -29% | -$63.4K | 0.04% | 685 |
|
|
2017
Q2 | $181K | Sell |
14,931
-47,450
| -76% | -$575K | 0.05% | 686 |
|
|
2017
Q1 | $802K | Buy |
+62,381
| New | +$802K | 0.1% | 347 |
|
|
2016
Q2 | – | Sell |
-112,403
| Closed | -$792K | – | 914 |
|
|
2016
Q1 | $792K | Buy |
+112,403
| New | +$792K | 0.09% | 374 |
|
|
2015
Q3 | – | Sell |
-56,300
| Closed | -$378K | – | 1073 |
|
|
2015
Q2 | $378K | Buy |
+56,300
| New | +$378K | 0.04% | 736 |
|